Back
ESC Premium Access

Proteomics profiling reveals distinct molecular subtypes of hypertrophic cardiomyopathy with differential risks of major adverse cardiovascular events

Session: Risk stratification in heart disease: the power of molecular tools
Topic: Hypertrophic Cardiomyopathy
Speaker: Doctor L. Liang (New York, US)
Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

Add to my library

Like

About the speaker

Doctor Lusha Liang

Columbia University Medical Centre, New York (United States of America)
0 follower

2 more presentations in this session

State-of-the-art in risk stratification in heart disease: the power of molecular tools

Speaker: Associate Professor J. Leopold (Boston, US)

Access
Slides
Video
Like
Thumbnail

Common genetic variants improve risk stratification after atrial switch operation for transposition of the great arteries

Speaker: Ms O. Woudstra (Amsterdam, NL)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Risk stratification in heart disease: the power of molecular tools

Speakers: Doctor L. Liang, Associate Professor J. Leopold, Ms O. Woudstra
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources